Update on HPV-induced oropharyngeal cancer;Aktuelles zu HPV-induzierten Oropharynxkarzinomen

HNO

Volumn 59, Issue 10, 2011, Pages 1031-1038

  Preuss, S F ^a   Klussmann, J P ^b   Semrau, R ^a   Huebbers, C ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Human papilloma virus DNA probes; Prognosis; Radiotherapy; Squamous cell carcinoma; Upper aerodigestive tract neoplasms

Indexed keywords

ARTICLE; CANCER STAGING; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; INDUCTION CHEMOTHERAPY; MULTIMODALITY CANCER THERAPY; OROPHARYNX TUMOR; PAPILLOMAVIRUS INFECTION; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DNA PROBES, HPV; GENES, P16; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INDUCTION CHEMOTHERAPY; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 80053247824     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-011-2391-z     Document Type: Article

References (19)

1. Marur S, D'Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11: 781-789.
2. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oralsquamous cell carcinomas in the United States. J Clin Oncol 26: 612-619.
3. Hammarstedt L, Lindquist D, Dahlstrand H et al (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119: 2620-2623.
4. D'Souza G, Agrawal Y, Halpern J et al (2009) Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 199: 1263-1269.
5. Smith EM, Ritchie JM, Summersgill KF et al (2004) Age, sexual behaviour and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108: 766-772.
6. Gillison ML, D'Souza G, Westra W et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100: 407-420.
7. Klussmann JP, Weissenborn SJ, Wieland U et al (2001) Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92: 2875-2884.
8. Klussmann JP, Preuss SF, Speel EJ (2009) Human papillomavirus and cancer of the oropharynx. Molecular interaction and clinical implications. HNO 57: 113-122.
9. Klussmann JP, Mooren JJ, Lehnen M et al (2009) Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15: 1779-1786.
10. Weinberger PM, Yu Z, Haffty BG et al (2006) Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24: 736-747.
11. Smeets SJ, Hesselink AT, Speel EJ et al (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121: 2465-2472.
12. Preuss SF, Dinh V, Klussmann JP et al (2007) Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience. Oral Oncol 43: 402-407.
13. Posner MR, Wirth LJ (2006) Cetuximab and radiotherapy for head and neck cancer. N Engl J Med 354: 634-636.
14. Preuss SF, Weinell A, Molitor M et al (2008) Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. Br J Cancer 98: 627-632.
15. Shi W, Kato H, Perez-Ordonez B et al (2009) Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 27: 6213-6221.
16. Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269.
17. Worden FP, Kumar B, Lee JS et al (2008) Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 26: 3138-3146.
18. Adelstein DJ, Ridge JA, Gillison ML et al (2009) Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington/DC. Head Neck 31: 1393-1422.
19. Leemans CR, Braakhuis BJM, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22.